entertainment -WSS

entertainment

author：focus 2025-10-02 16:18:44 - browse：8

As a new class of diabetes and obesity medications has soared in popularity, so have the online outlets built to get them in the hands of patients. A new analysis of claims data from Trilliant Health suggests that collectively, telehealth companies — in particular, cash-pay options that market directly to consumers — could account for many of the patients with insurance claims for GLP-1 prescriptions in 2022.

Direct-to-consumer telehealth companies have offered an easier on-ramp for many patients to access prescriptions for a variety of conditions. And since the first GLP-1s were approved for obesity — promising up to 15% weight loss — many of those companies have capitalized on the approvals and surging demand to launch new weight loss businesses. Companies including Calibrate and Ro claim to have reached tens and hundreds of thousands of patients with their weight loss medication programs.

Collectively, their reach may be even larger. The Trilliant Health analysis, conducted on behalf of STAT, offers an early glimpse of the foothold those businesses have gained in GLP-1 prescribing. In a nationwide claims database of more than 300 million patients using both commercial and federal insurance, Trilliant Health found about 3.6 million people with a prescription claim for a GLP-1 — semaglutide, tirzepatide, or injectable liraglutide without insulin — in 2022. To determine where each patient may have gotten those prescriptions, they looked for a medical visit claim within three days of a prescription claim for a GLP-1 — the visit where the script was likely written. But they only found a matching visit for 53% of patients.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Guidelines to prevent youth baseball injuries need more muscle
Next article： Is it ever OK for doctors to lie to their patients?

hotspot

WSS

UnitedHealth increases loan offers after Change Healthcare outage

Intermittent fasting comes with a heart risk? Not so fast

Black vets could get higher VA benefits if race not used in lung test

Colonoscopy prep: Liquid

Lawmakers grill UnitedHealth CEO on Change cyberattack

Nurses recount patients attacks

focus

entertainment

entertainment

Affirmative action in medical school literally saved lives

Class action alleges UnitedHealth concealed DOJ probe

Novavax promises a turnaround & Lilly roils the obesity market

AltruBio raises $225 million to develop ulcerative colitis drug

Supreme Court strikes down use of affirmative action

U.K. not yet recommending Vertex's CRISPR therapy for sickle cell

After affirmative action ruling, medical educators look to 'holistic review'

Future doctors should be trained to promote social change

What does generative AI mean for health care? We asked experts

Primary care doctor shortage won't be solved by free med school tuition

leisure time

U.K. researchers warn about biases in medical devices, algorithms

Has Bernie Sanders reached the limit of his pharma bullying effort?

Welsh Carson private equity firm escapes from FTC antitrust case

Class action alleges UnitedHealth concealed DOJ probe

5 to watch: Tech startups trying to solve health care's staffing crisis

I was wrong about Geron's blood cancer drug. Now, is it a takeover target?

hotspot

focus

Wikipedia

knowledge